Replies to post #219254 on Biotech Values

[DewDiligence]

From a regulatory standpoint, EOLS' product is a branded drug, not a biosimilar or generic. EOLS ran its own clinical trials in glabellar lines, so the FDA label (if the product is approved) will refer to EOLS' own data.